Dmd clinical therapies ii

In Duchenne muscular dystrophy (DMD), respiratory function decline leads to a high disease burden and early mortality. Data comparing the similarity and reliability of home-based respiratory assessments to hospital-based spirometry assessments had been lacking. In DELOS, respiratory function data were prospectively collected from 64 DMD patients aged 10-18 years, not taking glucocorticoids. All patients had established respiratory function decline (defined as peak expiratory flow

Source: Neuromuscular Disorders - September 6, 2018 Category: Neurology Authors: G. Buyse, T. Meier, M. Leinonen, S. Hasham, O. Mayer, T. Voit Source Type: research